Glomerulonephritis Patterns

Understanding the patterns of glomerular injury is essential for any clinician, as these diseases are a leading cause of chronic kidney disease worldwide. By correlating clinical syndromes with specific pathological findings, you can accurately diagnose conditions, predict outcomes, and initiate life-preserving treatments.

The Two Clinical Faces of Glomerular Disease

Glomerular diseases manifest primarily through two distinct clinical syndromes: nephritic syndrome and nephrotic syndrome. While overlap exists, recognizing their hallmark features is the first critical step in differential diagnosis.

Nephritic syndrome is characterized by inflammation within the glomerulus. The key features include hematuria (often visible as cola- or tea-colored urine), hypertension, mild to moderate proteinuria (usually less than 3.5 g/day), red blood cell casts on urinalysis, and a decline in kidney function indicated by a rising serum creatinine. Think of it as an "inflammatory attack" on the filtration barrier, where the primary problem is the leakage of red blood cells and a reduction in the kidney's filtering capacity.

In contrast, nephrotic syndrome results from a defect in the glomerular filtration barrier's integrity, leading to massive protein loss. Its defining features are heavy proteinuria (exceeding 3.5 g per day), hypoalbuminemia (low blood albumin), edema (swelling, often in the legs and around the eyes), and hyperlipidemia. Here, the problem is a "leaky sieve"; the inflammation is typically less prominent, but the loss of crucial proteins like albumin drives the systemic complications.

Common Glomerulonephritis Patterns: From Nephritic to Nephrotic

Glomerular diseases are classified by their histopathological patterns, which correlate strongly with these clinical presentations. A helpful framework is to categorize them based on which syndrome they most commonly produce.

Primary Nephritic Patterns often involve immune complex deposition or anti-glomerular basement membrane antibodies. A classic example is IgA nephropathy (Berger's disease), which is the most common glomerulonephritis worldwide. It typically presents with gross hematuria coinciding with an upper respiratory or gastrointestinal infection. The hallmark is the deposition of immunoglobulin A (IgA) in the mesangium of the glomerulus. Another important pattern is post-infectious glomerulonephritis, often following a streptococcal infection, characterized by "lumpy-bumpy" deposits on microscopy.

Primary Nephrotic Patterns in adults are often due to conditions that thicken or damage the glomerular basement membrane without prominent inflammation. The leading cause of nephrotic syndrome in non-diabetic adults is membranous nephropathy. This condition involves immune complexes (often antibodies against the phospholipase A2 receptor) depositing on the outer side of the glomerular basement membrane, causing it to thicken. This disrupts the charge and size barrier, leading to profound proteinuria. Other common nephrotic patterns include minimal change disease (common in children) and focal segmental glomerulosclerosis (FSGS).

The Diagnostic Cornerstone: Renal Biopsy and Pathology

While clinical and laboratory findings point toward a glomerular disease, a renal biopsy provides the definitive classification. The tissue is examined using three complementary techniques: light microscopy, immunofluorescence, and electron microscopy.

Light microscopy reveals the overall architecture, cellular proliferation, and scarring. Immunofluorescence is crucial for identifying the type, location, and pattern of immune deposits (e.g., granular IgA deposits in IgA nephropathy or linear IgG in anti-GBM disease). Electron microscopy offers ultra-structural detail, allowing you to see the precise location of deposits (subepithelial in membranous, mesangial in IgA) and foot process effacement (a hallmark of nephrotic syndromes like minimal change disease). This triad of findings is what allows pathologists to pinpoint the exact pattern of injury, moving from a clinical syndrome to a precise diagnosis.

Guiding Treatment Based on Pathology

The treatment strategy hinges on the specific pattern identified by the biopsy, as the underlying disease mechanisms differ. The mainstay for many proliferative, inflammatory (nephritic) diseases like severe IgA nephropathy or lupus nephritis is immunosuppressive therapy. This may include corticosteroids combined with agents like cyclophosphamide or mycophenolate mofetil to dampen the immune attack on the glomeruli.

For nephrotic syndromes, treatment varies. Membranous nephropathy may be managed conservatively with angiotensin-converting enzyme (ACE) inhibitors and statins, with immunosuppressants (like rituximab or cyclosporine) reserved for high-risk patients. Minimal change disease is highly responsive to corticosteroids. In all cases, supportive care to control blood pressure (with ACE inhibitors or ARBs, which also reduce proteinuria), manage edema, and treat hyperlipidemia is a foundational component of management.

Common Pitfalls

1. Confusing the Syndromes: Assuming a patient with edema must have nephrotic syndrome. Correction: Always check the urine dipstick and spot urine protein-to-creatinine ratio. Congestive heart failure and liver disease can cause edema without significant proteinuria. Conversely, not all hematuria is nephritic; other urological causes must be ruled out.

1. Overlooking the Role of Biopsy: Delaying a biopsy because a patient has "typical" lab findings. Correction: Biopsy is often essential even in classic presentations to confirm the diagnosis, assess the chronicity (amount of scarring), and guide specific therapy. Two patients with nephrotic syndrome may have minimal change disease or FSGS, which have very different treatments and prognoses.

1. Misinterpreting Serology: Relying solely on blood tests like anti-nuclear antibody (ANA) or complement levels for diagnosis. Correction: These are supportive markers. For example, low complement levels may suggest lupus nephritis or post-infectious GN, but the biopsy pattern dictates the specific treatment protocol and prognosis. The tissue diagnosis is definitive.

1. Neglecting Supportive Care: Focusing only on immunosuppression for a nephrotic patient. Correction: Immunosuppressants address the cause, but concurrent management of hypertension, hypercoagulable state (due to loss of anticoagulant proteins), and infection risk (due to loss of immunoglobulins) is critical to prevent acute complications.

Summary

• Glomerular diseases present as either nephritic syndrome (hematuria, hypertension, renal dysfunction) or nephrotic syndrome (heavy proteinuria, edema, hypoalbuminemia), driven by inflammatory or permeability defects, respectively.
• IgA nephropathy is the most common glomerulonephritis globally and typically presents with nephritic features, often following mucosal infections.
• In adults, membranous nephropathy is the leading cause of primary nephrotic syndrome, characterized by immune deposits thickening the glomerular basement membrane.
• The definitive diagnostic tool is a renal biopsy, analyzed by light microscopy, immunofluorescence, and electron microscopy to identify the precise pattern of injury.
• Treatment is guided by histopathology, ranging from immunosuppressive therapy for inflammatory patterns to targeted immunomodulation and robust supportive care for nephrotic conditions.